Elationship between promoter methylation & tissue expression of MGMT gene in ovarian cancer

Indian Journal of Medical Research

Volumn 140, Issue , 2014, Pages 616-623

  Shilpa, V ^a   Bhagat, Rahul ^a   Premalata, C S ^a   Pallavi, V R ^a   Ramesh, G ^a   Krishnamoorthy, Lakshmi ^a  

^a KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY   (India)

Author keywords

Epithelial ovarian tumour; MGMT; Ovarian cancer; Promoter methylation; Protein expression

Indexed keywords

METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; DNA LIGASE; DNA METHYLTRANSFERASE; MGMT PROTEIN, HUMAN; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; CANCER STAGING; CONTROLLED STUDY; CPG ISLAND; DNA EXTRACTION; DNA METHYLATION; DNA MODIFICATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVARY CARCINOMA; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN EXPRESSION; TISSUE MICROARRAY; YOUNG ADULT; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; OVARY TUMOR; PATHOLOGY;

ADULT; AGED; DNA METHYLATION; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; PROMOTER REGIONS, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 84920492001     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Strathdee G, Brown R. Aberrant DNA methylation in cancer: potential clinical interventions. Expert Rev Mol Med 2002; 4: 1-17.
2. Ludlum DB. DNA alkylation by the haloethylnitrosoureas: nature of modifications produced and their enzymatic repair or removal. MutatRes 1990; 233: 117-26.
3. Pegg AE. Repair of O6-alkylguanine by alkyltransferases. Mutat Res 2000; 462: 83-100.
4. Ogino S, Meyerhardt JA, Kawasaki T, Clark JW, Ryan DP. Kulke MH, et al. CpG island methylation, response to combination chemotherapy, and patient survival in advanced microsatellite stable colorectal carcinoma. Virchows Arch 2007; 450: 529-37.
5. Rodriguez MJ, Acha A, Ruesga MT, Rodriguez C, Rivera JM, Aguirre JM. Loss of expression of DNA repair enzyme MGMT in oral leukoplakia and early oral squamous cell carcinoma. A prognostic tool? Cancer Lett 2007, 245: 263-8.
6. Ishii T, Murakami J, Notohara K, Cullings HM, Sasamoto H, Kambara T, et al. Oesophageal squamous cell carcinoma may develop within a background of accumulating DNA methylation in normal and dysplastic mucosa. Gut 2007; 56: 13-9.
7. Weaver KD, Grossman SA, Herman JG. Methylated tumor- specific DNA as a plasma biomarker in patients with glioma. Cancer Invest 2006; 24: 35-40.
8. Ozols RF, Schwartz PE, Eifel PJ. Ovarian cancer, peritoneal carcinoma, and fallopian tube carcinoma. In: DeVita VT Jr., Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology, Section 32.4, 7th ed. Philadelphia: Lippincott, Williams and Wilkins; 2005. p. 1364-98.
9. Colombo N, Van Gorp T, Parma G, Amant F, Gatta G, Sessa C, et al. Ovarian cancer. Crit Rev Oncol Hematol 2006; 60: 159-79.
10. Goff BA, Mandel LS, Melancon CH, Muntz HG. Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. JAMA 2004; 291: 2705-12.
11. Prat J; FIGO Committee on Gynecologic Oncology. Staging classification for cancer of the ovary, fallopian tube and peritoneum. Int J Gynecol Obstet 2014; 124: 1-5.
12. Shah N, Lin B, Sibenaller Z, Ryken T, Lee H, Yoon J-G, et al. Comprehensive analysis of MGMT promoter methylation: Correlation with MGMT expression and clinical response in GBM. PLoS One 2011; 6: e16146.
13. Dhillon VS, Young AR, Husain SA, Aslam M. Promoter hypermethylation of MGMT, CDH1, RAR-f and SYK tumor suppressor genes in granulose cell tumors (GCTs) of ovarian origin. Br J Cancer 2004; 90: 874-81.
14. Cankovic M, Mikkelsen T, Rosenblum ML, Zarbo RJ. A simplified laboratory validated assay for MGMT promoter hypermethylation analysis of glioma specimens from formalin- fixed paraffin-embedded tissue. Lab Invest 2007; 87: 392-7.
15. Esteller M, Hamilton SR, Burger PC, Baylin SB, Herman JG. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 1999; 59: 793-7.
16. Jiaze A, Qingyi W, Zhensheng L, Karen H L, Xi C, Gordon BM, et al. Messenger RNA expression and methylation of candidate tumor-suppressor genes and risk of ovarian cancer- a case-control analysis. Int J Mol Epidemiol Genet 2010; 1: 1-10.
17. Furlan D, Carnevali I, Marcomini B, Cerutti R, Dainese E, Capella C, et al. The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas. Clin Cancer Res 2006; 12: 3329-36.
18. Imura M, Yamahita S, Cai LY, Furuta J, Wakabayashi M, Yasugi T, et al. Methylation and expression analysis of 15 genes and three normally-methylated genes in 13 ovarian cancer cell lines. Cancer Lett 2006; 241: 213-20.
19. Rodriguez FJ, Thibodeau SN, Jenkins RB, Schowatler KV, Caron BL, O’neill BP, et al. MGMT immunohistochemical expression and promoter methylation in human glioblastoma. Appl Immunohistochem Mol Morphol 2007; 16: 59-65.
20. Rimel BJ, Huettnetr P, Powell MA, Mutch DG, Paul J. Absence of MGMT promoter methylation in endometrial cancer. Gynecol Oncol 2009, 112: 224-8.
21. Brell M, Tor tosa A, Verger E, Gil GM, Vinolas N, Villa S, et al. Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas. Clin Cancer Res 2005; 11: 5167-74.
22. Roh HJ, Suh DS, Choi KU, Yoo HJ, Joo WD, Yoon MS. Inactivation of O6-methyguanine-DNA methyltransferase (MGMT) by promoter hypermethylation: A key factor of epithelial ovarian carcinogenesis in specific histologic types. J Obstet Gynaecol Res 2011; 37: 851-60.
23. Pieper RO, Patel S, Ting SA, Futscher BW, Costello JF. Methylation of CpG island transcription factor binding sites is unnecessary for aberrant silencing of the human MGMT gene. J Biol Chem 1996; 271: 13916-24.
24. Turker MS. Gene silencing in mammalian cells and the spread of DNA methylation. Oncogene 2002; 21: 5388-93.
25. Clark SJ, Melki J. DNA methylation and gene silencing in cancer: which is the guilty party? Oncogene 2002; 21: 5380-7.
26. Thomas M, Christoph B, Osman El-Maarri, Anika H, Denise E, Johannes S, et al. Optimization of quantitative MGMT promoter methylation analysis using pyrosequencing and combined bisulfite restriction analysis. J Mol Diagn 2007; 9: 368-81.